American Renal Associates Holdings Cash Flow - Quarterly (NYSE:ARA)

Add to My Stocks
$15.05 $0.37 (2.52%) ARA stock closing price Aug 16, 2017 (Closing)

The American Renal Associates Holdings cash flow statement is one of the three reports that the company generates every quarter. While its important to look at the American Renal Associates Holdings debt position, the cash flow statement becomes equally important because public companies use accrual accounting. For example, if a company sells a product which gets counted as American Renal Associates Holdings revenue but does not convert to cash because it does not receive payment in the same quarter, it affects the cash position for that period. American Renal Associates Holdings issued $0.51M worth of ARA shares. The cash flow statement helps in the American Renal Associates Holdings stock analysis by providing more information for evaluating changes in assets, liabilities and equities. ARA decrease in investments stood at a negative value of $-14.05M for the latest 2017-Q2. View details of American Renal Associates Holdings cash flows for latest & last 40 quarters.

show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec.2017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q1
American Renal Associates Holdings Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow19.52M9.6M36.45M27.04M17.73M8.47M34.73M24.99M16.6M8.45M
Net Increase (Decrease) in Assets Liabilities-8.29M-11.56M14.33M26.24M18.78M3.95M2.52M8.48M0.06M-2M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net11.84M5.57M33.21M16.96M16.53M1.57M3.25M5.68M3.39M2.56M
American Renal Associates Holdings Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-14.05M-6.4M-61.43M-46.65M-34.22M-16.39M-46.27M-37.89M-27.89M-10.99M
Acquisition Disposition of Subsidiaires---4.5M-4.46M-0.8M--2.64M-0.6M-0.6M-0.6M
Increase (Decrease) in Investments----------
Other Cash Inflow (Outflow) from Investment Activities----------
American Renal Associates Holdings Net Cash from (used by) Invesment Activities
Issuance (Purchase) of Equity Shares0.54M0.03M175.06M174.89M175.3M-0.65M0.76M0.07M-0.05M
Issuance (Repayment) of Debt Securities-2.34M-4.8M-144.65M-151.33M-156.04M4.82M19.26M20.19M21.06M1.71M
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions-8.68M-0.27M-30.24M-30.22M-30.17M-----
Other Cash from (used by) Financing Activities-53.7M-21.88M-96.51M-69.95M-40.79M-20M-75.09M-58.6M-41.51M-19.03M
American Renal Associates Holdings Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash----------
American Renal Associates Holdings Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year90.98M61.47M32.87M31.02M------
Cash & Equivalents at Year End75.03M84.1M100.91M105.14M93.26M95.96M90.98M89.84M74.43M60.1M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Cash flow for another ticker

While American Renal Associates Holdings stock price history provides the price history of a stock, American Renal Associates Holdings stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:
  • American Renal Associates Holdings saw a decrease in Net Change in Cash and Cash Equivalents from $-16.81M in 2017-Q1 to $-25.88M in 2017-Q2. Apart from the American Renal Associates Holdings stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • Cash Flow from operating activities: American Renal Associates Holdings reported a positive operating cash flow of $52.36M for 2017-Q2 and has seen an increase from the previous quarter. Operating cash flow or working capital comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Growth companies (typically most tech companies) spend heavily  on investing activities and this figure was negative at $-14.05M for ARA stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. American Renal Associates Holdings spent $37.27M from financing activities,in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.

Key Financial Ratios For American Renal Associates Holdings Cash Flow

FCF margin